The constipatory effects of oxodipine, a dihyrdopyridine-type calcium antagonist, have been described in a 3-mo, 12-mo, and 30-mo feeding toxicity study in rats. This paper reports the occurrence of megacolon in rats as a result of the constipatory effects of chronic administration of oxodipine. The first mortality due to oxodipine was seen after about 1 yr of treatment at a dose of 225 mg/kg/day. The toxic effects noted were dose-, time-, and sex-related. Female rats appeared more sensitive to the constipatory effects of the drug. The dose at which the effect occurred in both male and female rats was from about 75 to 675 times the recommended therapeutic dose for humans. To the best knowledge of the authors, this is the first report of a calcium channel blocker causing constipation in rats.
Barbara L., Corinaldesi R., and Baldi F. (1984). Effects of pinaverium bromide on intestinal transit time and sigmoid contractile activity in patients with chronic idiopathic constipation. Farm Ter. 1: 43-46.
2.
Barone FC, White RF, Oresbee HS 3rd, and Wasserman MA (1986). Effects of calcium channel entry blockers, nifedipine and nilvadipine, on colonic motor activity. J. Pharmacol. Exp. Ther. 273: 99-106.
3.
Brunton LL (1990). Agents affecting gastrointestinal water flux and motility, digestants, and bile acids, In: The Pharmacological Basis of Therapeutics, AG Gilman, TW Rall, AS Nies , and P Taylor (eds). Pergamon Press, New York, pp. 914-932.
4.
Committee on the Care and Use of Laboratory Animals (1985). Guide of the Care and Use of Laboratory Animals. NIH Publication No. 80-23, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, National Institute of Health, US Department of Health and Human Services , Washington, D.C.
5.
De Ponti F., D'Angelo L., Frigo GM, and Crema A. (1989). Inhibitory effects of calcium channel blockers on intestinal moltility in the dog. Eur. J. Pharmacol. 168: 133-144.
6.
Fleischman RW , McCracken D., and Forbes W. (1977). Adynamic ileus in the rat induced by chloral hydrate. Lab. Anim. Sci. 27: 238-243.
7.
Fonseca I., Martinez Carrera, S., and Garcia-Blanco S. (1986). Structure of oxodipine: New calcium antagonist. Acta Crystallogr. 42: 1792-1794.
8.
Forguel E., Chaussade S., and Roche H. (1990). Effects of an intestinal smooth muscle calcium channel blocker (pinaverium bromide) on colonic transit time in humans. J. Gastrointest. Motil. 2: 176-179.
9.
Galiano A. (1987). Oxodipine. Drugs Future12: 623-624.
10.
Goto S., Billmire, DF, and Grosfeld JL (1992). Hypothyroidism impairs colonic motility and function. An experimental study in the rat. Eur. J. Pediatr. Surg. 2: 16-21.
11.
Krevsky B., Maurer AH, Niewiarowski T., and Cohen S. (1991). Effect of verapamil on human intestinal transit . Dig. Dis. Sci. 37: 919-924.
12.
Logan RL (1988). The efficacy and tolerance in three doses of diltiazem in elderly patients with stable angina. Eur. J. Clin. Pharmacol . 33: 561-564.
13.
Marad F. (1990). Drugs used for treatment of angina: Organic nitrates, calcium channel blockers, and β-adrenergic antagonists. In: The Pharmacological Basis of Therapeutics, AG Gilman, TW Rall, AS Nies, and P Taylor (eds). Pergamon Press, New York , pp. 764-783.
14.
Sentander R. , Mana I., and Gramisu RW (1988). Effect of nifedipine on gastric emptying and gastrointestinal motility in man. Dig. Dis. Sci. 33: 535-539.
15.
Starling JR (1983). Treatment of non-toxic megacolon by colonoscopy. Surgery94: 677-682.
16.
Traube LS, Lange RC, McAllister RC, and McCallum RW (1982). Effect of nifedipine on gastric emptying. Sem. Nucl. Med. 12: 116-125.
17.
Uccheddu A. , Murgia C., Licheri S., Dessy E., Ghinami E., Scattone S., and Catetti M. (1991). The incidence of 1,2-dimethylhydrazine-induced colonic neoplasms in the rat: The effect of constipation. G. Chir. 12: 572-574.
18.
Waner T., Nyska A., Nyska M., Sela M., Pirak M., and Galiano A. (1988). Oxodipine induced gingival hyperplasia in dogs . Toxicol. Pathol. 16: 327-332.
